AVMA Voices Concerns About DEA Scheduling Process

Drug availability continues to be top of mind for AVMA members, and availability of controlled substances, including anesthetic drugs, is no exception. The AVMA’s Council on Biologic and Therapeutic Agents and its Clinical Practitioners Advisory Committee recently recommended AVMA submit to the Drug Enforcement … read more >

Committee members share their experiences, learn from others at 2014 VLC

Members from the Early Career Development Committee (ECDC) arrived at the 2014 Veterinary Leadership Conference (VLC) with one burning question, “How can I share my experience in organized veterinary medicine to help others understand what and why we do what … read more >

Drug Enforcement Administration Seeks Scheduling of Tramadol

Citing increasing evidence of substantial abuse and diversion of tramadol, the Drug Enforcement Administration (DEA) proposes oversight of tramadol as a Schedule IV substance. The DEA seeks comments on the proposed scheduling of tramadol through January 3, 2014. Recognizing the value … read more >